HalioDx
Veracyte helps doctors make better cancer and disease diagnoses with immuno-oncology diagnostic technologies, including Immunoscore®.
51-200 employees · est. 2014 · Marseille, France
Janux Therapeutics
Developing unique immunotherapies that generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue
120 employees · est. 2017 · San Diego, United States
HalioDx is the older company (2014 vs 2017).
Side-by-Side Comparison
| Metric | HalioDx | Janux Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2017 |
| Headquarters | ||
| Headquarters | Marseille, France | San Diego, United States |
| Employees | ||
| Employees | 51-200 | 120 |
| Industry | ||
| Industry | Health Care, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | IPO |
| Total Funding | ||
| Total Funding | $26.50M | $825.30M |
| Funding Rounds | ||
| Funding Rounds | 2 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Diagnostics, Oncology, Immuno-oncology, Precision Medicine, Cancer Diagnosis, Biomarker Development, Immunoscore®, Clinical Decision Support, Biopharma Collaborations, Immune Contexture Analysis | Biopharmaceutical, Cancer Therapy, T Cell Engagers, Oncology, Immune System Modulation, Solid Tumors, Drug Development, Oncology Research, Immune-mediated Therapies |
| Website | ||
| Website | haliodx.com | januxrx.com |
About HalioDx
HalioDx is a global diagnostics company that focuses on improving patient care through its immuno-oncology diagnostic technologies and services. Formerly known as HalioDx, the company operates in the Health Care and Pharmaceutical sectors and is headquartered in France. One of their flagship offerin...
About Janux Therapeutics
Janux Therapeutics is an innovative biopharmaceutical company founded in 2017 and based in the United States. The company is focused on developing next-generation therapeutics through its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology with the aim of providing more effective...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at HalioDx and Janux Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at HalioDx and Janux Therapeutics — by email.
Frequently Asked Questions
Compare HalioDx with someone else
Start typing a company name or domain.